EMAIL THIS PAGE TO A FRIEND

Molecular pharmacology

The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro.


PMID 25814515

Abstract

COH29 [N-(4-(3,4-dihydroxyphenyl)-5-phenylthiazol-2-yl)-3,4-dihydroxybenzamide], a novel antimetabolite drug developed at City of Hope Cancer Center, has anticancer activity that stems primarily from the inhibition of human ribonucleotide reductase (RNR). This key enzyme in deoxyribonucleotide biosynthesis is the target of established clinical agents such as hydroxyurea and gemcitabine because of its critical role in DNA replication and repair. Herein we report that BRCA-1-defective human breast cancer cells are more sensitive than wild-type BRCA-1 counterparts to COH29 in vitro and in vivo. Microarray gene expression profiling showed that COH29 reduces the expression of DNA repair pathway genes, suggesting that COH29 interferes with these pathways. It is well established that BRCA1 plays a role in DNA damage repair, especially homologous recombination (HR) repair, to maintain genome integrity. In BRCA1-defective HCC1937 breast cancer cells, COH29 induced more double-strand breaks (DSBs) and DNA-damage response than in HCC1937 + BRCA1 cells. By EJ5- and DR-green fluorescent protein (GFP) reporter assay, we found that COH29 could inhibit nonhomologous end joining (NHEJ) efficiency and that no HR activity was detected in HCC1937 cells, suggesting that repression of the NHEJ repair pathway may be involved in COH29-induced DSBs in BRCA1-deficient HCC1937 cells. Furthermore, we observed an accumulation of nuclear Rad51 foci in COH29-treated HCC1937 + BRCA1 cells, suggesting that BRCA1 plays a crucial role in repairing and recovering drug-induced DNA damage by recruiting Rad51 to damage sites. In summary, we describe here additional biologic effects of the RNR inhibitor COH29 that potentially strengthen its use as an anticancer agent.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

GW21985 Anti-CDKN1B antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
GW22609 Anti-CDKN1B antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1405601
Anti-CDKN1B antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2100391
Anti-CDKN1B antibody produced in rabbit, affinity isolated antibody
F2178 Anti-FKHRL1 (FOXO3a) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4500941
Anti-FKHRL1 antibody produced in rabbit, affinity isolated antibody
AV38040
Anti-FOXO3 antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB3500508
Anti-FOXO3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1411796
ANTI-FOXO3A antibody produced in mouse, clone 3F12, purified immunoglobulin, buffered aqueous solution
SAB1411797
ANTI-FOXO3A antibody produced in mouse, clone 2H2, purified immunoglobulin, buffered aqueous solution
SAB1411798
ANTI-FOXO3A antibody produced in mouse, clone 1D2, purified immunoglobulin, buffered aqueous solution
SAB1411799
ANTI-FOXO3A antibody produced in mouse, clone 2C4, purified immunoglobulin, buffered aqueous solution
SAB1411800
ANTI-FOXO3A antibody produced in mouse, clone 2D1, purified immunoglobulin, buffered aqueous solution
SAB1411801
ANTI-FOXO3A antibody produced in mouse, clone 4E8, purified immunoglobulin, buffered aqueous solution
SAB1411802
ANTI-FOXO3A antibody produced in mouse, clone 2C5, purified immunoglobulin, buffered aqueous solution
SAB1411803
ANTI-FOXO3A antibody produced in mouse, clone 3C2, purified immunoglobulin, buffered aqueous solution
SAB1411806
ANTI-FOXO3A antibody produced in mouse, clone 4F2, purified immunoglobulin, buffered aqueous solution
SAB1411820
ANTI-FOXO3A antibody produced in mouse, clone 1E11, purified immunoglobulin, buffered aqueous solution
AV38041
Anti-FOXO3A antibody produced in rabbit, affinity isolated antibody
SAB1306621
ANTI-P27KIP1 (N-TERM S12) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
WH0001027M1
Monoclonal Anti-CDKN1B antibody produced in mouse, clone 4B4-E6, purified immunoglobulin, buffered aqueous solution
SAB1403659
Monoclonal Anti-CDKN1B, (C-terminal) antibody produced in mouse, clone 2F4, purified immunoglobulin, buffered aqueous solution
F1304
Monoclonal Anti-FKHRL1 (FOXO3a) antibody produced in mouse, clone FR1, purified immunoglobulin, buffered aqueous solution
P2092
Monoclonal Anti-p27Kip1 antibody produced in mouse, clone DCS-72, ascites fluid